Novartis Announces Collaboration and Licensing Agreement with Surface Oncology

By: via Benzinga
Novartis (NYSE: NVS) continues to grow immuno-oncology pipeline through collaboration and licensing agreement with Surface Oncology ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.